Recorded: 23 Feb 2012
Well the only-- I mean the most, almost painful memory I have of a Cold Spring Harbor meeting was the meeting on virology, 1962. I gave a talk on Rous sarcoma virus, I had done a study with fluorescent anti-bodies Rous sarcoma virus. And a French scientist who will remain unnamed got up and absolutely destroyed me. And I was just a young post-doc, and I didn't know how to reply. Eventually Harry Rubin and some other people got up and defended me, and so... But I remember that. So the meetings were very, how should I say, very much alive, and people would readily ask questions, even if they appeared aggressive, overly aggressive. And I think that was actually a good feature of the Cold Spring Harbor meetings. It was this direct exchange, this openness, this honesty and even aggressiveness. It was good.
Dr. Peter Vogt, M.D., Ph.D., serves as Member of Scientific Advisory Board of Onconova Therapeutics, Inc. Dr. Vogt is at the Scripps Institute in La Jolla, CA. He is a member of the National Academy of Sciences and a Lasker Award winner. His fundamental studies on oncogenic avian retroviruses led to the identification of oncogenes in human cells. Dr. Vogt is the editor-in-chief of Virology, a scientific journal.
Dr. Peter Vogt intends to continue his work at the Scripps Research Institute. He is currently working to generate small molecule inhibitors that interfere with the spread of cancer as a new therapeutic approach.